These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 20196958)
1. [Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line]. Peng L; Xu Z; Zhou Y; Yang T; Liang ZQ; Zhang M Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):148-9. PubMed ID: 20196958 [No Abstract] [Full Text] [Related]
2. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165 [TBL] [Abstract][Full Text] [Related]
3. EB1089 induces Skp2-dependent p27 accumulation, leading to cell growth inhibition and cell cycle G1 phase arrest in human hepatoma cells. Luo W; Chen Y; Liu M; Du K; Zheng G; Cai T; Zhang W; Zhao F; Yao T; Yang R; Chen J Cancer Invest; 2009 Jan; 27(1):29-37. PubMed ID: 19160095 [TBL] [Abstract][Full Text] [Related]
4. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1. Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760 [TBL] [Abstract][Full Text] [Related]
5. [Expressions of Thr187 phosphorylated p27(kip1) and Skp2 proteins in human hepatocellular carcinomas and their significances]. Wang Y; Chen L; Lu MD; Li P; Cui XP; Qin J; Shen AG Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):943-4. PubMed ID: 18171537 [No Abstract] [Full Text] [Related]
6. Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma. Qi M; Liu D; Zhang S; Hu P; Sang T Mol Med Rep; 2015 May; 11(5):3934-40. PubMed ID: 25572801 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716 [TBL] [Abstract][Full Text] [Related]
9. Silibinin efficacy against human hepatocellular carcinoma. Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307 [TBL] [Abstract][Full Text] [Related]
10. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685 [TBL] [Abstract][Full Text] [Related]
11. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Lai PB; Chi TY; Chen GG Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126 [TBL] [Abstract][Full Text] [Related]
12. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway]. Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054 [TBL] [Abstract][Full Text] [Related]
13. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Fuke H; Shiraki K; Sugimoto K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Masuya M; Takei Y Biochem Biophys Res Commun; 2007 Nov; 363(3):738-44. PubMed ID: 17904524 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
15. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946 [TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate. Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104 [TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840 [TBL] [Abstract][Full Text] [Related]
19. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma. Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119 [TBL] [Abstract][Full Text] [Related]
20. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2]. Lu HQ; Zheng J Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]